Automation options and decisions made in implementing FLIPRTM
2000
Automation in High-Throughput Cell Screening
publication
Evidence: moderate
Author Information
Author(s): Derek J. Hook
Primary Institution: NPS Pharmaceuticals
Hypothesis
Can minimal automation improve throughput in high-throughput screening for smaller pharmaceutical companies?
Conclusion
The study found that process optimization and minimal automation can significantly enhance throughput in resource-constrained environments.
Supporting Evidence
- Throughput increased from two runs of eight plates per day to 64 plates per day after implementing the FLIPRTM.
- The study saved about $50,000 in materials costs by reducing wasted plates from 50% to less than 5%.
- Integration of the screening team improved workflow and efficiency in the screening process.
Takeaway
This study shows that smaller companies can use simple machines to do a lot of tests quickly, just like big companies do.
Methodology
The study involved evaluating automation options for high-throughput screening and implementing a FLIPRTM system at NPS Pharmaceuticals.
Limitations
The study was limited to a single case at NPS Pharmaceuticals and may not generalize to all pharmaceutical companies.
Want to read the original?
Access the complete publication on the publisher's website